Recent studies indicate that ETS family genes, particularly ETS1 and FLI- 1, may play significant roles in the pathophysiology of hematopoiesis. This information, however, is based primarily on analysis of gene knockout mice and studies of human cell lines in culture. In project #3 we propose to carry out direct study of primary murine and human hematopoietic cells in order to delineate the physiological functions of ETS1 and FLI-1 in hematopoiesis. The cells will be harvested directly from mice or man, or prepared in primary suspension or methylcellulose culture.
In specific aim #1 RT-PCR and immunohistochemical techniques will be used for study of the gene expression by cells representing different lineages and stages of hematopoietic development. Lineage restricted pure populations of mature cells and highly enriched populations of monopotential and multi-potential progenitors will be prepared by combinations of techniques including Fluorescence-Activated Cell Sorter (FACS) cell sorting and methylcellulose clonal cell culture. Ultimately, we will analyze the gene expression by individual hemopoietic progenitors by use of single cell RT-PCR.
In specific aim #2 the effects of inhibition and forced expression of ETS1 and FLI-1 genes on the differentiation of hematopoietic progenitors will be studied by using retroviral transfection. We will construct vectors contain E-coli beta-galactosidase (beta-gal) gene and sense or antisense sequences of one ETS family gene in order to distinguish clearly the transduced from non-transduced cells. FACS-enriched progenitors will be exposed to the retroviral vectors under appropriate cell culture conditions, sorted again for beta-gal+ cells and the samples will be plate in methylcellulose culture for colony formation. The effects on lineage expression by murine cells will be correlated with the hematopoietic abnormalities seen in their respective gene knockout mice. Comparisons with the cell culture studies of human cells will provide insight into the roles of FLI-1 and ETS1 genes in the pathophysiology of human hematopoiesis.
|Scheiber, Melissa N; Watson, Patricia M; Rumboldt, Tihana et al. (2014) FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression. Neoplasia 16:801-13|
|Kornblau, Steven M; Qiu, Yi Hua; Zhang, Nianxiang et al. (2011) Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia. Blood 118:5604-12|
|Turner, David P; Findlay, Victoria J; Moussa, Omar et al. (2011) Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. Prostate 71:1723-35|
|Markiewicz, Margaret; Nakerakanti, Sashidhar S; Kapanadze, Bagrat et al. (2011) Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells. Microcirculation 18:1-11|
|Findlay, Victoria J; Turner, David P; Yordy, John S et al. (2011) Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms. Genes Cancer 2:120-9|
|Duchi, Serena; Fagnocchi, Luca; Cavaliere, Valeria et al. (2010) Drosophila VHL tumor-suppressor gene regulates epithelial morphogenesis by promoting microtubule and aPKC stability. Development 137:1493-503|
|Asano, Yoshihide; Stawski, Lukasz; Hant, Faye et al. (2010) Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol 176:1983-98|
|Moussa, Omar; LaRue, Amanda C; Abangan Jr, Romeo S et al. (2010) Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1. Mol Cell Biol 30:5194-206|
|Elkareh, Jihad; Periyasamy, Sankaridrug M; Shidyak, Amjad et al. (2009) Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. Am J Physiol Renal Physiol 296:F1219-26|
|Shirai, Keisuke; Sera, Yasuhiko; Bulkeley, William et al. (2009) Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia. Exp Hematol 37:1464-71|
Showing the most recent 10 out of 84 publications